304 related articles for article (PubMed ID: 30523026)
1. FoxO Transcription Factors Are Critical Regulators of Diabetes-Related Muscle Atrophy.
O'Neill BT; Bhardwaj G; Penniman CM; Krumpoch MT; Suarez Beltran PA; Klaus K; Poro K; Li M; Pan H; Dreyfuss JM; Nair KS; Kahn CR
Diabetes; 2019 Mar; 68(3):556-570. PubMed ID: 30523026
[TBL] [Abstract][Full Text] [Related]
2. Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy.
Milan G; Romanello V; Pescatore F; Armani A; Paik JH; Frasson L; Seydel A; Zhao J; Abraham R; Goldberg AL; Blaauw B; DePinho RA; Sandri M
Nat Commun; 2015 Apr; 6():6670. PubMed ID: 25858807
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
Reed SA; Sandesara PB; Senf SM; Judge AR
FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth.
Lee D; Goldberg AL
J Biol Chem; 2013 Oct; 288(42):30515-30526. PubMed ID: 24003218
[TBL] [Abstract][Full Text] [Related]
5. Loss of FoxOs in muscle reveals sex-based differences in insulin sensitivity but mitigates diet-induced obesity.
Penniman CM; Suarez Beltran PA; Bhardwaj G; Junck TL; Jena J; Poro K; Hirshman MF; Goodyear LJ; O'Neill BT
Mol Metab; 2019 Dec; 30():203-220. PubMed ID: 31767172
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis.
Choi S; Jeong HJ; Kim H; Choi D; Cho SC; Seong JK; Koo SH; Kang JS
Autophagy; 2019 Jun; 15(6):1069-1081. PubMed ID: 30653406
[TBL] [Abstract][Full Text] [Related]
7. Sestrin prevents atrophy of disused and aging muscles by integrating anabolic and catabolic signals.
Segalés J; Perdiguero E; Serrano AL; Sousa-Victor P; Ortet L; Jardí M; Budanov AV; Garcia-Prat L; Sandri M; Thomson DM; Karin M; Hee Lee J; Muñoz-Cánoves P
Nat Commun; 2020 Jan; 11(1):189. PubMed ID: 31929511
[TBL] [Abstract][Full Text] [Related]
8. Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis.
O'Neill BT; Lee KY; Klaus K; Softic S; Krumpoch MT; Fentz J; Stanford KI; Robinson MM; Cai W; Kleinridders A; Pereira RO; Hirshman MF; Abel ED; Accili D; Goodyear LJ; Nair KS; Kahn CR
J Clin Invest; 2016 Sep; 126(9):3433-46. PubMed ID: 27525440
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase 6 is a FoxO transcription factor-dependent effector in skeletal muscle atrophy.
Ratti F; Ramond F; Moncollin V; Simonet T; Milan G; Méjat A; Thomas JL; Streichenberger N; Gilquin B; Matthias P; Khochbin S; Sandri M; Schaeffer L
J Biol Chem; 2015 Feb; 290(7):4215-24. PubMed ID: 25516595
[TBL] [Abstract][Full Text] [Related]
10. Insulin and IGF-1 receptors regulate complex I-dependent mitochondrial bioenergetics and supercomplexes via FoxOs in muscle.
Bhardwaj G; Penniman CM; Jena J; Suarez Beltran PA; Foster C; Poro K; Junck TL; Hinton AO; Souvenir R; Fuqua JD; Morales PE; Bravo-Sagua R; Sivitz WI; Lira VA; Abel ED; O'Neill BT
J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34343133
[TBL] [Abstract][Full Text] [Related]
11. Regulation of muscle atrophy-related genes by the opposing transcriptional activities of ZEB1/CtBP and FOXO3.
Ninfali C; Siles L; Darling DS; Postigo A
Nucleic Acids Res; 2018 Nov; 46(20):10697-10708. PubMed ID: 30304480
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
[TBL] [Abstract][Full Text] [Related]
13. cAMP-dependent protein kinase inhibits FoxO activity and regulates skeletal muscle plasticity in mice.
Silveira WA; Gonçalves DA; Machado J; Lautherbach N; Lustrino D; Paula-Gomes S; Pereira MG; Miyabara EH; Sandri M; Kettelhut IC; Navegantes LC
FASEB J; 2020 Sep; 34(9):12946-12962. PubMed ID: 32772437
[TBL] [Abstract][Full Text] [Related]
14. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells.
Zhao J; Brault JJ; Schild A; Cao P; Sandri M; Schiaffino S; Lecker SH; Goldberg AL
Cell Metab; 2007 Dec; 6(6):472-83. PubMed ID: 18054316
[TBL] [Abstract][Full Text] [Related]
15. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
[TBL] [Abstract][Full Text] [Related]
16. A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle.
Crossland H; Constantin-Teodosiu D; Gardiner SM; Constantin D; Greenhaff PL
J Physiol; 2008 Nov; 586(22):5589-600. PubMed ID: 18818241
[TBL] [Abstract][Full Text] [Related]
17. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome.
Sandri M
Int J Biochem Cell Biol; 2013 Oct; 45(10):2121-9. PubMed ID: 23665154
[TBL] [Abstract][Full Text] [Related]
18. Muscle immobilization activates mitophagy and disrupts mitochondrial dynamics in mice.
Kang C; Yeo D; Ji LL
Acta Physiol (Oxf); 2016 Nov; 218(3):188-197. PubMed ID: 27083499
[TBL] [Abstract][Full Text] [Related]
19. Coordinate activation of autophagy and the proteasome pathway by FoxO transcription factor.
Zhao J; Brault JJ; Schild A; Goldberg AL
Autophagy; 2008 Apr; 4(3):378-80. PubMed ID: 18227643
[TBL] [Abstract][Full Text] [Related]
20. Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy.
Hulmi JJ; Silvennoinen M; Lehti M; Kivelä R; Kainulainen H
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E307-15. PubMed ID: 22068602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
